|
ZNF329 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77479997365282E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.83749999847083E-08 |
| Normal-vs-Stage2 |
2.757500E-04 |
| Normal-vs-Stage3 |
3.61169999996136E-06 |
| Normal-vs-Stage4 |
4.25830004591177E-09 |
| Stage1-vs-Stage2 |
5.353200E-01 |
| Stage1-vs-Stage3 |
1.190850E-01 |
| Stage1-vs-Stage4 |
1.158470E-02 |
| Stage2-vs-Stage3 |
4.825200E-01 |
| Stage2-vs-Stage4 |
1.521170E-01 |
| Stage3-vs-Stage4 |
4.618600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.2480999807899E-09 |
| Normal-vs-AfricanAmerican |
6.54209999950695E-07 |
| Normal-vs-Asian |
3.204100E-04 |
| Caucasian-vs-AfricanAmerican |
7.344600E-01 |
| Caucasian-vs-Asian |
6.101000E-01 |
| AfricanAmerican-vs-Asian |
6.568000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.81880083111241E-11 |
| Normal-vs-Female |
1.443900E-02 |
| Male-vs-Female |
8.264200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.04509999999214E-05 |
| Normal-vs-Extreme_Weight |
3.88609999735223E-09 |
| Normal-vs-Obese |
3.029000E-04 |
| Normal-vs-Extreme_Obese |
9.480600E-03 |
| Normal_Weight-vs-Extreme_Weight |
6.205800E-01 |
| Normal_Weight-vs-Obese |
3.678200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.310000E-01 |
| Extreme_Weight-vs-Obese |
1.134430E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.342600E-01 |
| Obese-vs-Extreme_Obese |
3.259400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.115200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.88909999998543E-06 |
| Normal-vs-Age(61-80Yrs) |
6.31569996301096E-09 |
| Normal-vs-Age(81-100Yrs) |
1.324840E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.816800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.649200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.419600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.579600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.011200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.546600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.96680000000382E-06 |
| Normal-VS-Type2 PRCC |
3.71599995219185E-09 |
| Normal-VS-KIRP CIMP |
3.305000E-03 |
| Normal-VS-Unclassified PRCC |
4.771500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.495100E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.233390E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.854600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.636400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.093200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.266400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.80479964306812E-10 |
| Normal-vs-N1 |
7.04289999986507E-07 |
| Normal-vs-N2 |
3.14200000017806E-07 |
| N0-vs-N1 |
8.936400E-01 |
| N0-vs-N2 |
2.446400E-01 |
| N1-vs-N2 |
1.904040E-01 |
|
|
